Small is a Powerful Ingredient for Patient-Centric Formulations
Patient centricity is driving change in drug discovery and development, leading to a a new dawn in therapeutics.
Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
Addressing Developmental Challenges of Gene Therapy Viral Vectors
Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.
Improved Formulations to Enable Stable Delivery of Biologics
How dry powder techniques can overcome limitations in biologics development and delivery to broaden routes of administration and global accessibility.
Nitrosamides–Should They Be Treated the Same as Nitrosamines?
The authors discuss the differences in mechanism of activation of N-nitrosamides versus N-nitrosamines and the fact that they should not be treated the same.
Emerging Applications of Vitamin E TPGS in Drug Delivery
The author discusses some new applications of TPGS in the pharmaceutical field that should see this versatile excipient retain its place in the drug formulators toolbox.
